Top

Published in:

01-12-2014 | Update in Gnathic Pathology. Guest Editors: Angela Chi, DMD and John Wright, DDS

The Diagnostic Usefulness of Immunohistochemistry for Odontogenic Lesions

Authors: Keith D. Hunter, Paul M. Speight

Published in: Head and Neck Pathology | Issue 4/2014

Abstract

The diagnosis of odontogenic tumors can be challenging, largely due to their rarity and consequent difficulties in gaining experience in their assessment. In most cases, careful attention to morphology, in conjunction with clinical and radiological features will allow a diagnosis to be made. However, in some cases, immunohistochemical analysis of the tumor may be useful. In this review we will outline the immunohistochemical expression profile of normal developing odontogenic tissues and a range of odontogenic tumors. In many cases the immunohistochemical markers are neither specific nor sensitive enough to be of help in diagnosis, but in some cases such analysis may prove very useful. Thus we have outlined a limited number of circumstances where immunohistochemistry may be of use to the practicing diagnostic pathologist.

Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology and genetics of head and neck tumors. World Health Organization classification. Lyon: IARC Press; 2005.

Crivelini MM, de Araujo VC, de Sousa SOM, de Araujo NS. Cytokeratins in epithelia of odontogenic neoplasms. Oral Dis. 2003;9(1):1–6.PubMedCrossRef

Domingues MG, Jaeger MM, Araujo VC, Araujo NS. Expression of cytokeratins in human enamel organ. Eur J Oral Sci. 2000;108(1):43–7.PubMedCrossRef

Juuri E, Isaksson S, Jussila M, Heikinheimo K, Thesleff I. Expression of the stem cell marker, SOX2, in ameloblastoma and dental epithelium. Eur J Oral Sci. 2013;121(6):509–16.PubMedCrossRef

Hamamoto Y, Nakajima T, Ozawa H, Uchida T. Production of amelogenin by enamel epithelium of Hertwig’s root sheath. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(6):703–9.PubMedCrossRef

Rincon JC, Young WG, Bartold PM. The epithelial cell rests of Malassez—a role in periodontal regeneration? J Periodontal Res. 2006;41(4):245–52. doi:10.1111/j.1600-0765.2006.00880.x.PubMedCrossRef

Bille ML, Nolting D, Kjaer I. Immunohistochemical studies of the periodontal membrane in primary teeth. Acta Odontol Scand. 2009;67(6):382–7. doi:10.1080/00016350903160589.PubMedCrossRef

Nel S, Van Heerden MB, Steenkamp G, Van Heerden WF, Boy SC. Immunohistochemical profile of odontogenic epithelium in developing dog teeth (Canis familiaris). Vet Pathol. 2011;48(1):276–82. doi:10.1177/0300985810374843.PubMedCrossRef

Gonzalez-Alva P, Inoue H, Miyazaki Y, Tsuchiya H, Noguchi Y, Kikuchi K, et al. Podoplanin expression in odontomas: clinicopathological study and immunohistochemical analysis of 86 cases. J Oral Sci. 2011;53(1):67–75.PubMedCrossRef

10.

Ide F, Obara K, Yamada H, Mishima K, Saito I, Horie N, et al. Hamartomatous proliferations of odontogenic epithelium within the jaws: a potential histogenetic source of intraosseous epithelial odontogenic tumors. J Oral Pathol Med. 2007;36(4):229–35.PubMedCrossRef

11.

Fukumashi K, Enokiya Y, Inoue T. Cytokeratins expression of constituting cells in ameloblastoma. Bull Tokyo Dent Coll. 2002;43(1):13–21.PubMedCrossRef

12.

Pal SK, Sakamoto K, Aragaki T, Akashi T, Yamaguchi A. The expression profiles of acidic epithelial keratins in ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(4):523–31.PubMedCrossRef

13.

Kishino M, Murakami S, Yuki M, Iida S, Ogawa Y, Kogo M, et al. A immunohistochemical study of the peripheral ameloblastoma. Oral Dis. 2007;13(6):575–80. doi:10.1111/j.1601-0825.2006.01340.x.PubMedCrossRef

14.

Bologna-Molina R, Mosqueda-Taylor A, Molina-Frechero N, Mori-Estevez A-D, Sanchez-Acuna G. Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors. Med Oral Patol Oral Cir Bucal. 2013;18(2):e174–9.PubMedCentralPubMedCrossRef

15.

Otero D, Lourenco SQ, Ruiz-Avila I, Bravo M, Sousa T, de Faria PA, et al. Expression of proliferative markers in ameloblastomas and malignant odontogenic tumors. Oral Dis. 2013;19(4):360–5. doi:10.1111/odi.12010.PubMedCrossRef

16.

Yoon HJ, Jo BC, Shin WJ, Cho YA, Lee JI, Hong SP, et al. Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(6):767–76. doi:10.1016/j.tripleo.2011.06.036.PubMedCrossRef

17.

Gomes CC, Duarte AP, Diniz MG, Gomez RS. Review article: current concepts of ameloblastoma pathogenesis. J Oral Pathol Med. 2010;39(8):585–91. doi:10.1111/j.1600-0714.2010.00908.x.PubMedCrossRef

18.

Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, de Almeida OP, Carrasco-Daza D, Farfan-Morales JE, et al. Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma. Pathol Int. 2009;59(4):229–33. doi:10.1111/j.1440-1827.2009.02355.x.PubMedCrossRef

19.

Cairns L, Naidu A, Robinson CM, Sloan P, Wright JM, Hunter KD. CD56 (NCAM) expression in ameloblastomas and other odontogenic lesions. Histopathology. 2010;57(4):544–8.PubMedCrossRef

20.

Kusafuka K, Hirobe K, Wato M, Tanaka A, Nakajima T. CD56 expression is associated with neuroectodermal differentiation in ameloblastomas: an immunohistochemical evaluation in comparison with odontogenic cystic lesions. Med Mol Morphol. 2011;44(2):79–85.PubMedCrossRef

21.

Altini M, Coleman H, Doglioni C, Favia G, Maiorano E. Calretinin expression in ameloblastomas. Histopathology. 2000;37(1):27–32.PubMedCrossRef

22.

Anandani C, Metgud R, Singh K. Calretinin as a diagnostic adjunct for ameloblastoma. Pathol Res Int. 2014;2014:308240.CrossRef

23.

Coleman H, Altini M, Ali H, Doglioni C, Favia G, Maiorano E. Use of calretinin in the differential diagnosis of unicystic ameloblastomas. Histopathology. 2001;38(4):312–7.PubMedCrossRef

24.

D’Silva S, Sumathi MK, Balaji N, Shetty NK, Pramod KM, Cheeramelil J. Evaluation of calretinin expression in ameloblastoma and non-neoplastic odontogenic cysts—an immunohistochemical study. J Int Oral Health JIOH. 2013;5(6):42–8.

25.

Shear M, Speight PM. Cysts of the oral and maxillofacial regions. 4th ed. Oxford: Blackwell Munksgaard; 2008.

26.

Li TJ. The odontogenic keratocyst: a cyst, or a cystic neoplasm? J Dent Res. 2011;90(2):133–42. doi:10.1177/0022034510379016.PubMedCrossRef

27.

Vered M, Peleg O, Taicher S, Buchner A. The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts. J Oral Pathol Med. 2009;38(7):597–604.PubMedCrossRef

28.

Diniz MG, Gomes CC, de Castro WH, Guimaraes ALS, De Paula AMB, Amm H, et al. miR-15a/16-1 influences BCL2 expression in keratocystic odontogenic tumors. Cell Oncol. 2012;35(4):285–91.CrossRef

29.

Azevedo RS, Mosqueda-Taylor A, Carlos R, Cabral MG, Romanach MJ, de Almeida OP, et al. Calcifying epithelial odontogenic tumor (CEOT): a clinicopathologic and immunohistochemical study and comparison with dental follicles containing CEOT-like areas. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(6):759–68.PubMedCrossRef

30.

Ren C, Diniz MG, Piazza C, Amm HM, Rollins DL, Rivera H, et al. Differential enamel and osteogenic gene expression profiles in odontogenic tumors. Cells Tissues Organs. 2011;194(2–4):296–301.PubMedCrossRef

31.

Crivelini MM, Felipini RC, Miyahara GI, de Sousa SCOM. Expression of odontogenic ameloblast-associated protein, amelotin, ameloblastin, and amelogenin in odontogenic tumors: immunohistochemical analysis and pathogenetic considerations. J Oral Pathol Med. 2012;41(3):272–80.PubMedCrossRef

32.

Angiero F, Crippa R. Adenomatoid odontogenic tumor: a case report with immunohistological profile. Anticancer Res. 2013;33(6):2673–7.PubMed

33.

Leon JE, Mata GM, Fregnani ER, Carlos-Bregni R, de Almeida OP, Mosqueda-Taylor A, et al. Clinicopathological and immunohistochemical study of 39 cases of adenomatoid odontogenic tumour: a multicentric study. Oral Oncol. 2005;41(8):835–42. doi:10.1016/j.oraloncology.2005.04.008.PubMedCrossRef

34.

Alaeddini M, Etemad-Moghadam S, Baghaii F. Comparative expression of calretinin in selected odontogenic tumours: a possible relationship to histogenesis. Histopathology. 2008;52(3):299–304. doi:10.1111/j.1365-2559.2007.02948.x.PubMedCrossRef

35.

Razavi SM, Tabatabaie SH, Hoseini AT, Hoseini ET, Khabazian A. A comparative immunohistochemical study of Ki-67 and Bcl-2 expression in solid ameloblastoma and adenomatoid odontogenic tumor. Dent Res J. 2012;9(2):192–7.CrossRef

36.

Saxena K, Jose M, Chatra LK, Sequiera J. Adenoid ameloblastoma with dentinoid. J Oral Maxillofac Pathol. 2012;16(2):272–6. doi:10.4103/0973-029X.99088.PubMedCentralPubMedCrossRef

37.

Philipsen HP, Reichart PA. Squamous odontogenic tumor (SOT): a benign neoplasm of the periodontium. A review of 36 reported cases. J Clin Periodontol. 1996;23(10):922–6.PubMedCrossRef

38.

Kaminagakura E, Domingos PL, da Rosa MR, Loyola AM, Cardoso SV, Lopes MC, et al. Detection of cytokeratins in ghost cells of calcifying cystic odontogenic tumor indicates an altered keratinization and hair follicle differentiation for their development. Ann Diagn Pathol. 2013;17(6):514–7. doi:10.1016/j.anndiagpath.2013.07.002.PubMedCrossRef

39.

Gong Y, Wang L, Wang H, Li T, Chen X. The expression of NF-kappaB, Ki-67 and MMP-9 in CCOT, DGCT and GCOC. Oral Oncol. 2009;45(6):515–20.PubMedCrossRef

40.

Yoshida M, Kumamoto H, Ooya K, Mayanagi H. Histopathological and immunohistochemical analysis of calcifying odontogenic cysts. J Oral Pathol Med. 2001;30(10):582–8.PubMedCrossRef

41.

Lee SK, Kim YS. Current concepts and occurrence of epithelial odontogenic tumors: II. calcifying epithelial odontogenic tumor versus ghost cell odontogenic tumors derived from calcifying odontogenic cyst. Korean J Pathol. 2014;48(3):175–87. doi:10.4132/KoreanJPathol.48.3.175.PubMedCentralPubMedCrossRef

42.

Takeda Y, Sato H, Satoh M, Nakamura SI, Yamamoto H. Immunohistochemical expression of neural tissue markers (neuron-specific enolase, glial fibrillary acidic protein, S100 protein) in ameloblastic fibrodentinoma: a comparative study with ameloblastic fibroma. Pathol Int. 2000;50(8):610–5.PubMedCrossRef

43.

Mosqueda-Taylor A, Martinez-Mata G, Carlos-Bregni R, Vargas PA, Toral-Rizo V, Cano-Valdez AM, et al. Central odontogenic fibroma: new findings and report of a multicentric collaborative study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(3):349–58. doi:10.1016/j.tripleo.2011.03.021.PubMedCrossRef

44.

Martinez-Mata G, Mosqueda-Taylor A, Carlos-Bregni R, de Almeida OP, Contreras-Vidaurre E, Vargas PA, et al. Odontogenic myxoma: clinico-pathological, immunohistochemical and ultrastructural findings of a multicentric series. Oral Oncol. 2008;44(6):601–7. doi:10.1016/j.oraloncology.2007.08.009.PubMedCrossRef

45.

Lombardi T, Lock C, Samson J, Odell EW. S100, alpha-smooth muscle actin and cytokeratin 19 immunohistochemistry in odontogenic and soft tissue myxomas. J Clin Pathol. 1995;48(8):759–62.PubMedCentralPubMedCrossRef

46.

Graadt van Roggen JF, Hogendoorn PC, Fletcher CD. Myxoid tumours of soft tissue. Histopathology. 1999;35(4):291–312.PubMedCrossRef

47.

Lei Y, Jaradat JM, Owosho A, Adebiyi KE, Lybrand KS, Neville BW et al. Evaluation of SOX2 as a potential marker for ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(5):608–616.

48.

Li TJ, Yu SF, Gao Y, Wang EB. Clear cell odontogenic carcinoma: a clinicopathologic and immunocytochemical study of 5 cases. Arch Pathol Lab Med. 2001;125(12):1566–71.PubMed

49.

Premalatha BR, Rao RS, Patil S, Neethi H. Clear cell tumors of the head and neck: an overview. World J Dent. 2012;3(4):344–9.CrossRef

50.

Bilodeau EA, Hoschar AP, Barnes EL, Hunt JL, Seethala RR. Clear cell carcinoma and clear cell odontogenic carcinoma: a comparative clinicopathologic and immunohistochemical study. Head Neck Pathol. 2011;5(2):101–7.PubMedCentralPubMedCrossRef

51.

Bilodeau EA, Weinreb I, Antonescu CR, Zhang L, Dacic S, Muller S, et al. Clear cell odontogenic carcinomas show EWSR1 rearrangements: a novel finding and a biological link to salivary clear cell carcinomas. Am J Surg Pathol. 2013;37(7):1001–5.PubMedCrossRef

52.

Bishop JA, Yonescu R, Batista D, Warnock GR, Westra WH. Glandular odontogenic cysts (GOCs) lack MAML2 rearrangements: a finding to discredit the putative nature of GOC as a precursor to central mucoepidermoid carcinoma. Head Neck Pathol. 2014;8(3):287–90. doi:10.1007/s12105-014-0534-8.PubMedCrossRef

Title: The Diagnostic Usefulness of Immunohistochemistry for Odontogenic Lesions
Authors: Keith D. Hunter
Paul M. Speight
Publication date: 01-12-2014
Publisher: Springer US
Published in: Head and Neck Pathology / Issue 4/2014
Electronic ISSN: 1936-0568
DOI: https://doi.org/10.1007/s12105-014-0582-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Diagnostic Usefulness of Immunohistochemistry for Odontogenic Lesions

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2014

Metastatic Tumors to the Jaws and Mouth

Osteochemonecrosis: An Overview

Giant Cell Lesions of the Craniofacial Bones

Recent Developments in Metabolic Bone Diseases: a Gnathic Perspective

Odontogenic Tumors, WHO 2005: Where Do We Go from Here?

An Update on Gnathic Pathology